Loading...
OTCM
GBCS
Market cap17mUSD
Oct 01, Last price  
5.73USD
Name

Selectis Health Inc

Chart & performance

D1W1MN
OTCM:GBCS chart
P/E
—
P/S
0.42
EPS
—
Div yield, %
—
Shrs. gr., 5y
-0.26%
Rev. gr., 5y
14.64%
Revenues
41m
+4.94%
3,738,0003,578,0004,402,0005,952,0005,952,0005,516,0005,155,0003,137,0001,831,0003,407,0002,860,0003,130,0003,623,0006,930,00020,929,00029,287,00040,600,00036,783,00039,492,00041,441,030
Net income
-1m
L-58.10%
119,077123,636-11,467-1,111,000-1,379,000-866,000-1,864,000-1,807,0001,357,000-3,335,000-1,152,000-2,997,000-1,992,000-862,0002,956,000-2,252,000-2,396,000-3,971,000-2,424,000-1,015,752
CFO
2m
P
644,748861,234584,466767,642368,277300,870-22,28439,743-626,783-30,855-506,953218,252108,188868,9212,734,207-270,930-305,148536,666-1,824,4371,882,030
Dividend
Jul 20, 20150.01 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Selectis Health, Inc. is a healthcare owner-operator that acquires, develops, and manages skilled nursing facilities, assisted living facilities, and independent living facilities across the South and Southeastern United States. The Company currently operates eight properties in Arkansas and Oklahoma, providing post-acute and skilled nursing care, assisted and independent living services, and continuing care retirement programs, with reimbursement sourced through Medicare, Medicaid, and private pay arrangements. Selectis is focused on delivering quality resident care while pursuing strategic growth opportunities in an expanding senior healthcare market. Selectis Health, Inc. was established and incorporated on June 08, 1978, in Utah.

Key people

Zvi Michael Rhine
President, Chief Financial Officer, Director · since 2017
Andrew L. Sink
Interim Chief Operating Officer, Independent Director · since 2017
Clifford L. Neuman
Director · since 2016
Adam Arthur Desmond
Independent Director · since 2017
URL
https://www.selectis.com
IPO date
Jun 25, 2001
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT